Product Details

Biaxin

Clarithromycin
250 mg/5 mL
Suspension


DIN/PIN/NPN

02244641

Manufacturer

BGP Pharma ULC

Formulary Listing Date

2003-01-30  

Unit Price

0.6466

Amount MOH Pays

0.4685

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Antibiotics, Erythromycins (08:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.

ATC Code

J01FA09

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02390450 Taro-Clarithromycin 0.4685 0.4685
02244641 Biaxin 0.6466 0.4685
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph